IP Library › Granted Patent US 9,668,811
Granted Patent B2
US 9,668,811 · App. 13/243,134 · Granted Jun 6, 2017

Minimally invasive access for renal nerve ablation

Inventors: David J. Sogard (Edina, MN); Scott Smith (Chaska, MN); Mark L. Jenson (Greenfield, MN)
Assignee: Boston Scientific Scimed, Inc.
A61B18/1492A61N5/062A61B90/37A61B2018/00404A61B2018/00434A61B2018/00511A61B2018/00577A61B2018/00791A61B2018/00875A61B2018/0212A61N7/022A61N2005/067A61N2007/003
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,668,811
App. No.
13/243,134
Granted
Jun 6, 2017
Kind
B2
Abstract

An elongated flexible medical device is inserted into a patient's body via a natural orifice, and advanced through the natural orifice to a location proximate innervated tissue that influences renal sympathetic nerve activity. The medical device can be advanced into a body organ and to a location within the organ proximate the innervated tissue. The organ may comprise an organ of the gastrointestinal tract or urinary tract. The medical device may be advanced through and beyond an access hole in a wall of the organ, and situated at a location proximate the innervated tissue. One or both of imaging and ablation energy is delivered from a distal end of the medical device to the innervated tissue. Innervated renal tissue can be ablated using various forms of energy, including RF energy, ultrasound energy, optical energy, and thermal energy.

Claims (20)

1. A method, comprising:

inserting an elongated flexible medical device into a patient's body via a natural orifice;

wherein the natural orifice includes a urethra;

advancing the medical device through the urethra, through the bladder, and through a ureter to a location proximate innervated tissue that influences renal sympathetic nerve activity; and

delivering energy from a distal end of the medical device to one or both of image and ablate the innervated tissue.

2. The method of claim 1 , wherein delivering energy from the distal end of the medical device comprises delivering energy of sufficient power or intensity to one or both of ablate the innervated tissue and image the innervated tissue.

3. The method of claim 1 , wherein delivering energy from the distal end of the medical device comprises delivering energy of sufficient power or intensity to selectively image the innervated tissue and ablate the innervated tissue.

4. The method of claim 1 , wherein delivering energy from the distal end of the medical device comprises delivering energy of sufficient power or intensity to ablate the innervated tissue, the method further comprising imaging tissue of or proximate the innervated tissue using an external imaging device to facilitate ablation of the innervated tissue by the medical device.

5. The method of claim 1 , wherein delivering energy from the distal end of the medical device comprises ablating the innervated tissue using at least one of RF energy, ultrasound energy, optical energy, and thermal energy.

6. An apparatus, comprising:

an elongated flexible medical device configured for insertion into a patient's body via a natural orifice, the medical device being configured for and having a length sufficient for advancement through a urethra, through a bladder, and through a ureter to a position adjacent to a renal artery proximate innervated tissue that influences renal sympathetic nerve activity via an internal body pathway of the patient; and

an energy delivery device provided at a distal end of the medical device and configured to communicate energy to the location at or proximate the innervated tissue to one or both of image and ablate the innervated tissue.

7. The apparatus of claim 6 , wherein the energy delivery device comprises one or both of an ablation device configured to ablate the innervated tissue and an imaging device configured to image the innervated tissue.

8. The apparatus of claim 6 , wherein the energy delivery device comprises a device configured to selectively image the innervated tissue and ablate the innervated tissue.

9. The apparatus of claim 6 , wherein the energy delivery device comprises at least one of a radiofrequency ablation device, an ultrasound ablation device, an optical ablation device, and a thermal ablation device.

10. The apparatus of claim 6 , further comprising:

a second elongated flexible medical device configured for insertion into the patient's body and having a length sufficient for advancement to a second location at or proximate innervated tissue relative to a body access location of the patient; and

a second energy device provided at a distal end of the second medical device.

11. The apparatus of claim 10 , wherein the energy delivery device comprises an ablation device and the second energy delivery device comprises an imaging device.

12. The method of claim 1 , wherein advancing the medical device through the natural orifice, through the bladder, and into a ureter to a location proximate innervated tissue that influences renal sympathetic nerve activity includes advancing the medical device to a position adjacent to a renal artery.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 28, 2011
From: SOGARD, DAVID J.; SMITH, SCOTT; JENSON, MARK L.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 027285/0395 →
Continuity (3)
Provisional Application 61414299 · Nov 16, 2010
Provisional Application 61491731 · May 31, 2011
Related Publication 20120123303A1 · May 17, 2012